Leadiant Archives · BioBuzz

Five Biotechs Poised to Advance Their Rare Disease Programs [2022 updated]

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2020/01/Rare-Disease-RD-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2020/01/Rare-Disease-RD-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2020/01/Rare-Disease-RD-100x100.png?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2020/01/Rare-Disease-RD-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2020/01/Rare-Disease-RD.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2020/01/Rare-Disease-RD-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : January 28, 2020February 22, 2022 Published by : Steven Surdez

Five Biotechs Poised to Advance Their Rare Disease Programs [2022 updated] On the cusp of rare disease day, we’re checking in with Maryland biotech companies at the forefront of rare [….]

Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi™

<img width="300" height="300" src="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/11/Leadiant-rare-dedication-300x300.png?lossy=1&strip=1&webp=1" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image" alt="" decoding="async" loading="lazy" srcset="https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/11/Leadiant-rare-dedication-75x75.png?lossy=1&strip=1&webp=1 75w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/11/Leadiant-rare-dedication-100x100.png?lossy=1&strip=1&webp=1 100w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/11/Leadiant-rare-dedication-150x150.png?lossy=1&strip=1&webp=1 150w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/11/Leadiant-rare-dedication.png?size=240x240&lossy=1&strip=1&webp=1 240w, https://b2193782.smushcdn.com/2193782/wp-content/uploads/2018/11/Leadiant-rare-dedication-300x300.png?lossy=1&strip=1&webp=1 300w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : November 20, 2018November 20, 2018 Published by : Steven Surdez

Leadiant Shows Rare Dedication to Patients With Recent FDA Approval of Revcovi™ November 20, 2018 Leadiant Biosciences, Inc. formerly known as Sigma-Tau Pharmaceuticals, recently received FDA approval for Revcovi™, which [….]